New Delhi, Nov. 13 -- Biocon share price jumped over 4% to a fresh 52-week high on Thursday after reports stated that the company was evaluating an internal merger of its biosimilars arm, Biocon Biologics, with the parent entity. Biocon shares rallied as much as 4.01% to a new high of Rs.422.65 apiece on the BSE.

According to a report by The Economic Times, Biocon is in advanced discussions to restructure its wholly owned subsidiary Biocon Biologics, and is reviewing an initial public offering (IPO) and share swap with minority investors.

The move is part of the company's broader efforts to unlock shareholder value and reduce acquisition-related debt. Earlier, ET reported that the Bicon was exploring multiple strategic options, includin...